Pflug Koory’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $528K | Sell |
1,006
-2
| -0.2% | -$1.05K | 0.27% | 86 |
|
2025
Q1 | $639K | Sell |
1,008
-32
| -3% | -$20.3K | 0.36% | 71 |
|
2024
Q4 | $741K | Sell |
1,040
-8
| -0.8% | -$5.7K | 0.38% | 68 |
|
2024
Q3 | $1.1M | Buy |
+1,048
| New | +$1.1M | 0.54% | 55 |
|
2024
Q1 | $1.04M | Sell |
1,078
-5
| -0.5% | -$4.81K | 0.51% | 61 |
|
2023
Q4 | $951K | Sell |
1,083
-15
| -1% | -$13.2K | 0.5% | 59 |
|
2023
Q3 | $904K | Hold |
1,098
| – | – | 0.52% | 57 |
|
2023
Q2 | $789K | Sell |
1,098
-15
| -1% | -$10.8K | 0.4% | 70 |
|
2023
Q1 | $915K | Sell |
1,113
-30
| -3% | -$24.7K | 0.5% | 58 |
|
2022
Q4 | $825K | Sell |
1,143
-3
| -0.3% | -$2.17K | 0.46% | 65 |
|
2022
Q3 | $789K | Sell |
1,146
-14
| -1% | -$9.64K | 0.48% | 65 |
|
2022
Q2 | $686K | Hold |
1,160
| – | – | 0.4% | 72 |
|
2022
Q1 | $810K | Hold |
1,160
| – | – | 0.41% | 72 |
|
2021
Q4 | $733K | Hold |
1,160
| – | – | 0.37% | 73 |
|
2021
Q3 | $702K | Hold |
1,160
| – | – | 0.38% | 76 |
|
2021
Q2 | $648K | Hold |
1,160
| – | – | 0.34% | 84 |
|
2021
Q1 | $549K | Sell |
1,160
-31
| -3% | -$14.7K | 0.3% | 89 |
|
2020
Q4 | $575K | Buy |
1,191
+63
| +6% | +$30.4K | 0.34% | 82 |
|
2020
Q3 | $631K | Sell |
1,128
-5
| -0.4% | -$2.8K | 0.43% | 66 |
|
2020
Q2 | $707K | Hold |
1,133
| – | – | 0.52% | 56 |
|
2020
Q1 | $553K | Buy |
1,133
+625
| +123% | +$305K | 0.49% | 61 |
|
2019
Q4 | $191K | Buy |
+508
| New | +$191K | 0.14% | 150 |
|